Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
T C Thompson Children's Hospital
mi
from
Chattanooga, TN
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
T C Thompson Children's Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Texas Tech University Health Science Center-Amarillo
mi
from
Amarillo, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Texas Tech University Health Science Center-Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Baylor College of Medicine
mi
from
Houston, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Scott & White Memorial Hospital
mi
from
Temple, TX
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
University of Vermont
mi
from
Burlington, VT
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
University of Virginia
mi
from
Charlottesville, VA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Mary Bridge Children's Hospital and Health Center
mi
from
Tacoma, WA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Mary Bridge Children's Hospital and Health Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
West Virginia University Charleston
mi
from
Charleston, WV
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
West Virginia University Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Marshfield Clinic
mi
from
Marshfield, WI
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated:  9/7/2017
Sydney Children's Hospital
mi
from
Randwick,
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Status: Enrolling
Updated: 9/7/2017
Sydney Children's Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Donepezil HCl & Cognitive Deficits in Autism
Donepezil HCl: Treating Cognitive Deficits in Autism
Status: Enrolling
Updated:  9/7/2017
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Donepezil HCl & Cognitive Deficits in Autism
Donepezil HCl: Treating Cognitive Deficits in Autism
Status: Enrolling
Updated: 9/7/2017
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Simvastatin For Intracerebral Hemorrhage Study
Simvastatin For Intracerebral Hemorrhage Study
Status: Enrolling
Updated:  9/8/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Simvastatin For Intracerebral Hemorrhage Study
Simvastatin For Intracerebral Hemorrhage Study
Status: Enrolling
Updated: 9/8/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)
Status: Enrolling
Updated:  9/11/2017
OhioHealth
mi
from
Columbus, OH
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)
Status: Enrolling
Updated: 9/11/2017
OhioHealth
mi
from
Columbus, OH
Click here to add this to my saved trials
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Status: Enrolling
Updated:  9/12/2017
Xenoscience Inc.
mi
from
Phoenix, AZ
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Status: Enrolling
Updated: 9/12/2017
Xenoscience Inc.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Status: Enrolling
Updated:  9/12/2017
Compass Research LLC
mi
from
Orlando, FL
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Status: Enrolling
Updated: 9/12/2017
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury
Neurofeedback-enhanced Mindfulness Meditation for the Treatment of Affective and Attentional Disturbances in Patients With Traumatic Brain Injury
Status: Enrolling
Updated:  9/12/2017
Spaulding Rehabilitation Hospital Boston
mi
from
Charlestown, MA
Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury
Neurofeedback-enhanced Mindfulness Meditation for the Treatment of Affective and Attentional Disturbances in Patients With Traumatic Brain Injury
Status: Enrolling
Updated: 9/12/2017
Spaulding Rehabilitation Hospital Boston
mi
from
Charlestown, MA
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
New York, NY
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Durham, NC
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Cincinnati, OH
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Sacramento, CA
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Stanford, CA
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Gulf Breeze, FL
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Iowa City, IA
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Kansas City, KA
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Baltimore, MD
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Minneapolis, MN
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Columbus, OH
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Portland, OR
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Dallas, TX
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/13/2017
GSK Investigational Site
mi
from
Saint Louis, MO
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/13/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Folinic Acid Intervention for Autism Spectrum Disorders
A Folinic Acid Intervention for ASD: Links to Folate Receptor-alpha Autoimmunity & Redox Metabolism
Status: Enrolling
Updated:  9/13/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
A Folinic Acid Intervention for Autism Spectrum Disorders
A Folinic Acid Intervention for ASD: Links to Folate Receptor-alpha Autoimmunity & Redox Metabolism
Status: Enrolling
Updated: 9/13/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Brain Retraction Monitoring Sensor Study
Brain Retraction Monitoring Sensor
Status: Enrolling
Updated:  9/14/2017
Methodist Hospital
mi
from
Indianapolis, IN
Brain Retraction Monitoring Sensor Study
Brain Retraction Monitoring Sensor
Status: Enrolling
Updated: 9/14/2017
Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Brain Retraction Monitoring Sensor Study
Brain Retraction Monitoring Sensor
Status: Enrolling
Updated:  9/14/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Brain Retraction Monitoring Sensor Study
Brain Retraction Monitoring Sensor
Status: Enrolling
Updated: 9/14/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Brain Retraction Monitoring Sensor Study
Brain Retraction Monitoring Sensor
Status: Enrolling
Updated:  9/14/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Brain Retraction Monitoring Sensor Study
Brain Retraction Monitoring Sensor
Status: Enrolling
Updated: 9/14/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials